Corcept Therapeutics, Inc. (CORT)
34.64
+0.56
(+1.64%)
USD |
NASDAQ |
Mar 20, 16:00
35.01
+0.37
(+1.07%)
After-Hours: 20:00
Corcept Therapeutics Research and Development Expense (Quarterly) : 64.86M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | 48.68M |
| Integer Holdings Corp. | 10.11M |
| Harrow, Inc. | 3.273M |
| Ultragenyx Pharmaceutical, Inc. | 194.22M |
| Cytokinetics, Inc. | 101.54M |